Anti-Occludin (Marker of Early Blood Brain Barrier Damage) Monoclonal Antibody (Clone: OCLN/2181), Clone: [OCLN/2181], Mouse

Artikelnummer: ABI-36-2007-20
Artikelname: Anti-Occludin (Marker of Early Blood Brain Barrier Damage) Monoclonal Antibody (Clone: OCLN/2181), Clone: [OCLN/2181], Mouse
Artikelnummer: ABI-36-2007-20
Hersteller Artikelnummer: 36-2007-20
Alternativnummer: ABI-36-2007-20-20UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC, WB
Spezies Reaktivität: Human
Immunogen: Recombinant fragment of human Occludin protein (around aa 282-415) (exact sequence is proprietary)
Alternative Synonym: BLCPMG, Occludin, OCLN, Phosphatase 1 regulatory subunit 115, PTORCH1, Tight junction protein occludin
Occludin is a tetraspan integral membrane protein in epithelial and endothelial tight junction (TJ) structures that can contain two extracellular loops. The protein exists in a variety of phosphorylated forms. Phosphorylation is involved in regulating both the localization and the function of Occludin. Expression of Occludin is upregulated by polyunsaturated fatty acids, increasing trans-endothelial cell resistance and reducing cellular permeability to large molecules. The level of Occludin varies greatly depending on tissue, in brain tissue, Occludin is highly expressed at cell-cell contact sites. Non-neural tissues show lower expression and discontinuous distribution. Occludin is a tight junction protein that is a key structural component of the blood-brain barrier (BBB). Degradation of Occludin is frequently seen in ischemic stroke and contributes to BBB disruption.
Klonalität: Monoclonal
Klon-Bezeichnung: [OCLN/2181]
NCBI: 100506658
UniProt: Q16625
Application Verdünnung: Western Blot (1-2ug/ml),Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95C followed by cooling at RT for 20 minute